← Evidence map

ArticleClinical pharmacokinetics2022

Could Fluvoxamine Dose De-escalation Increase Treatment Compliance Without Sacrificing Efficacy in COVID-19 Patients?

Robert Marcec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35869361